Explore the vast range of titles available.

The term ‘cognitive reserve’ broadly refers to better-than-expected cognitive abilities in old age, presumed to reflect environmental/lifestyle factors earlier in life. This commentary addresses the question of what determines ‘better than expected’ cognition; specifically, whether cognitive reserve can be ‘explained away’ by considering multiple brain measurements. Using simulations, I show that, once one allows for multiple brain properties related to cognition, differential maintenance of those properties can reproduce the clinical picture associated with cognitive reserve. Using real data, I then show that white-matter microstructure and functional connectivity explain significant additional variance in fluid intelligence beyond grey-matter volume (at least cross-sectionally), supporting the importance of measuring multiple brain properties. Using multimodal, longitudinal data to identify changes in those brain properties that are especially important for changes in cognition will help decide which interventions are most likely to be effective at maintaining cognition in old age.

The primary objection to debiasing-training interventions is a lack of evidence that they improve decision making in field settings, where reminders of bias are absent. We gave graduate students in three professional programs (N = 290) a one-shot training intervention that reduces confirmation bias in laboratory experiments. Natural variance in the training schedule assigned participants to receive training before or after solving an unannounced business case modeled on the decision to launch the Space Shuttle Challenger. We used case solutions to surreptitiously measure participants’ susceptibility to confirmation bias. Trained participants were 19% less likely to choose the inferior hypothesis-confirming solution than untrained participants. Analysis of case write-ups suggests that a reduction in confirmatory hypothesis testing accounts for their improved decision making in the case. The results provide promising evidence that debiasing-training effects transfer to field settings and can improve decision making in professional and private life.

Longitudinal disease assessment by molecular techniques is not routine in hairy cell leukaemia (HCL). Combining and other genomic targets through next-generation sequencing (NGS) with phased variant analysis is a novel approach for disease detection in this setting. digital droplet PCR of paired peripheral blood and cell-free DNA (cfDNA) specimens detected residual disease in 15/48 and 6/48 specimens respectively from patients with HCL. NGS testing with phased variant analysis improved disease detection in cfDNA specimens, including those with equivocal results by digital droplet PCR. Through multiple patient-specific genomic targets to improve sensitivity, NGS may potentially improve disease detection in HCL. The authors have confirmed clinical trial registration is not needed for this submission.

To slow the spread of SARS-CoV-2, the German government released the “Corona-Warn-App”, a smartphone application that warns users if they have come into contact with other users tested positive for SARS-CoV-2. Since using the “Corona-Warn-App” is health-relevant behavior, it is essential to understand who is (and who is not) using it and why. In N = 1,972 German adults, we found that non-users were on average older, female, healthier, in training, and had low general trust in others. The most frequently named reasons by non-users were privacy concerns, doubts about the effectiveness of the app, and lack of technical equipment.

This is an account of the crucial role played by a strong local Aboriginal workforce in health care delivery. We report on the personal experience of dedicated Aboriginal health professionals across Western Australia. Their understanding of what has worked in the provision of primary health care in their communities emphasises the importance of strong, local collaboration in the development of effective prevention programmes at a community level.

The aim of this study was to explore the nature of clinical enquiries received by UK vaccination centres during the early stages in the roll-out of the COVID-19 vaccination programme. Four centres were situated in acute hospitals and one centre was in a designated public site. Data were collected for eight consecutive weeks between January and February 2021. The hospital centres administered a total of 28 995 doses of the Pfizer BioNTech vaccine, receiving 806 enquiries (1 enquiry per 36 vaccinations, 2.7%). The public centre administered 29 167 doses of AstraZeneca vaccine, receiving 439 enquiries (1 enquiry per 66 vaccinations, 1.5%). Combined enquiry rate was 2.1%. The most common enquiries were related to allergies (44%), compatibility with other medicine (22%) and immunosuppression (16%). These were the topics of clinical guidance that were subject to regular change. Public health programmes implementing novel therapies should ensure the provision of sufficient enquiry answering capacity.

Systemic chemotherapy has been shown to produce side effects. A small fraction of the drug reaches the tumor site; other healthy organs or normal tissues get affected or damaged due to the nonspecific action of these cytotoxic agents. Furthermore, due to their short period of activity, repeat injections are often required, which can lead to the exacerbation of side effects and inconvenience. To overcome these obstacles, in this study, we developed controlled and targeted intratumoral injection. Hydrogel was prepared by physical cross-linking method; however, nanohydrogel was prepared using tip probe-sonicator method. Our results revealed that biodegradable and thermosensitive 5-fluorouracil-loaded methylcellulose nanohydrogel synthesized by physical cross-linking method may be a beneficial approach in targeting the therapeutic agent to the tumor site.

This paper reports the fabrication of highly sensitive metformin sensor based on Prussian blue (PB) nanocubes/carbon nanosphere (CNS) heterostructures composed of a perfect cube and spherical composite on a fluorine-doped tin oxide surface. Due to the excellent biocompatibility of PB nanocubes the PB/CNS based Mf sensor exhibited a wide linear range of 0.001–10 mM with a response duration of less than 5 s and a detection limit (based on signal to noise ratio) of 0.1 µM.

Iron oxide nanoparticles have unique magnetic properties and therefore readily respond to applied magnetic fields. Moreover, their surfaces can be used to attach active molecules via various covalent or noncovalent interactions. Thus, they can be used as drug carriers for magnetically controlled delivery to specific biological sites of interest. In the present study, we have synthesized aqueous dispersed samples of citric acid-capped iron oxide nanoparticles, and the anticancer drug doxorubicin was then linked with these superparamagnetic iron oxide nanoparticles via a simple noncovalent interaction. Our results show that the conjugated drug releases from the nanoparticles in a sustained manner. The cellular uptake of these nanoparticles was found to be substantial, although it can be further enhanced using magnetic guidance. These nanoparticles (drug free) were found to be nontoxic to cells; however, upon drug conjugation, drug-induced toxicity was observed, owing to the slow release of drug from the nanoparticles.